Seeing Is Believing
AGLE is currently covered by 2 analysts with an average price target of $55.55. This is a potential upside of $27.95 (101.27%) from yesterday's end of day stock price of $27.6.
Aeglea Bio Therapeutics's activity chart (see below) currently has 12 price targets and 23 ratings on display. The stock rating distribution of AGLE is 66.67% BUY and 33.33% HOLD.
Analysts average stock forecasts to be materialized ratio is 51.19% with an average time for these price targets to be met of 236.57 days.
Highest price target for AGLE is $15, Lowest price target is $9, average price target is $17.5.
Most recent stock forecast was given by YANAN ZHU from WELLS FARGO on 12-Nov-2023. First documented stock forecast 02-May-2016.
Currently out of the existing stock ratings of AGLE, 2 are a BUY (66.67%), 1 are a HOLD (33.33%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$12
$-15.6 (-56.52%)
1 years 5 months 28 days ago
(12-Nov-2023)
2/2 (100%)
$1.82 (17.88%)
14
Buy
$23
$-4.6 (-16.67%)
$22.5
1 years 8 months ago
(10-Sep-2023)
2/2 (100%)
$8.95 (63.70%)
141
Hold
$25
$-2.6 (-9.42%)
2 years 2 months 8 days ago
(02-Mar-2023)
1/3 (33.33%)
$15.15 (153.81%)
325
Hold
$25
2 years 6 months 14 days ago
(26-Oct-2022)
1/4 (25%)
$6.75 (36.99%)
151
Buy
$11
2 years 11 months 7 days ago
(03-Jun-2022)
2/2 (100%)
$3.33 (40.64%)
1025
What is AGLE (Aeglea Bio Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?
Which analyst has the current lower performing score on AGLE (Aeglea Bio Therapeutics) with a proven track record?
Which analyst has the most public recommendations on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most bullish on AGLE (Aeglea Bio Therapeutics)?
Which analyst is the currently most reserved on AGLE (Aeglea Bio Therapeutics)?